Evidence for the release of 1-methyl-4-phenylpyridinium (MPP+) from rat striatal neurons in vitro

This publication has 6 references indexed in Scilit:

• Conversion of the neurotoxic precursor 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine into its pyridinium metabolite by human platelet monoamine oxidase type B
  Neuroscience Letters, 1985
• 1-methyl-4-phenylpyridine (MPP+) is toxic to mesencephalic dopamine neurons in culture
  Neuroscience Letters, 1985
• The Clinical Syndrome of Striatal Dopamine Deficiency
  New England Journal of Medicine, 1985
• Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity.
  Proceedings of the National Academy of Sciences, 1985
• IV. Differences in the metabolism of MPTP in the rodent and primate parallel differences in sensitivity to its neurotoxic effects
  Life Sciences, 1985
• Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism
  Nature, 1984